Manufacturing

Are Fossil Fuel Lobbyists Undermining the Plastics Treaty?
Manufacturing Are Fossil Fuel Lobbyists Undermining the Plastics Treaty?

In a critical moment for global environmental policy, the ongoing negotiations for a landmark plastics treaty at the Intergovernmental Negotiating Committee (INC-5.2) talks in Geneva have sparked intense debate over corporate influence. Reports reveal a staggering presence of at least 234 lobbyists

How Are U.S. Textile Giants Redefining Global Supply Chains?
Manufacturing How Are U.S. Textile Giants Redefining Global Supply Chains?

In a world where geopolitical tensions, trade tariffs, and supply chain disruptions have become the norm, the U.S. textile industry is undergoing a remarkable transformation that could reshape global markets. Far from being mere victims of circumstance, several major players in this sector are

How Will FDA PreCheck Boost U.S. Drug Manufacturing?
Manufacturing How Will FDA PreCheck Boost U.S. Drug Manufacturing?

Imagine a scenario where a global crisis disrupts the supply of critical medications, leaving the United States scrambling to secure essential drugs due to an overreliance on foreign production. Currently, over half of the pharmaceuticals distributed in the U.S. are manufactured overseas, with a

Greener Steel in Canada Faces Market Turmoil and Uncertainty
Manufacturing Greener Steel in Canada Faces Market Turmoil and Uncertainty

The steel industry in Canada stands at a critical juncture, with pioneering efforts to produce greener, low-emission steel clashing against a backdrop of severe market challenges and unpredictable future prospects. Companies like Algoma Steel Inc. have taken bold steps by integrating electric arc

US-EU Trade Deal Imposes 15% Tariff on Pharmaceuticals
Manufacturing US-EU Trade Deal Imposes 15% Tariff on Pharmaceuticals

The pharmaceutical industry is reeling from the announcement of a new US-EU trade agreement that imposes a 15% tariff on European drugs imported into the United States, marking a seismic shift in transatlantic trade relations and raising concerns about cost increases. Unveiled over the weekend,

How Is Merck Cutting $3 Billion to Fuel Future Growth?
Manufacturing How Is Merck Cutting $3 Billion to Fuel Future Growth?

Setting the Stage: Navigating a High-Stakes Pharmaceutical Landscape In an era where the pharmaceutical industry faces relentless pressure from patent cliffs and geopolitical uncertainties, Merck has unveiled a staggering $3 billion cost-cutting initiative to secure annual savings by the end of

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later